Orthogenrx Inc

FDA Filings

This page includes the latest FDA filings for Orthogenrx Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

Orthogenrx Inc holds import registrations or U.S. agent authorizations in conjunction with the following organizations:

• Meiji Pharma Spain

FDA Registration(s)

• Registration Number: 3011402886
• FEI Number: 3011402886
• Name: ORTHOGENRX, INC
• Owner & Operator: OrthogenRx, Inc.
• Contact Address: 2005 South Easton Road, Suite 207 ; Doylestown PA 18901 US
• Official Correspondent:
  • David Toledo-Velasquez
  • 1-215-9081357-x
• Registration Status: 1
• Initial Importer: Y
• Registration Expiration: 2020-04-25
• Registration Address: 2005 S EASTON RD STE 207 ; Doylestown, PA 18901 US
• Establishment Type: Complaint File Establishment per 21 CFR 820.198

FDA Filings

Device Company	Device	Date
PMA P160057S001 ORTHOGENRX,INC	TriVisc	2020-06-07
PMA P140005S004 ORTHOGENRX,INC	GenVisc 850	2020-06-07
GUDID 10850653006044 ORTHOGENRX, INC	TriVisc™ sodium hyaluronate	2019-01-21
PMN P160057 | MOZ ORTHOGENRX, INC [OrthogenRx, Inc.]	TriVisc	2018-10-03
GUDID 10850653006013 ORTHOGENRX, INC	GenVisc® 850 sodium hyaluronate	2018-07-06
PMA P160057 ORTHOGENRX,INC	TRIVISC	2017-11-13
PMN P140005 | MOZ ORTHOGENRX, INC [OrthogenRx, Inc.]	GenVisc 850 Sodium Hyaluronate	2015-12-17
PMA P140005 ORTHOGENRX,INC	GENVISC 850	2015-09-02

Related Finance Registrations

SEC

0001584198

OrthogenRx, Inc. of PENNSYLVANIA